MFC Co., Ltd. (KRX:432980)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,955.00
0.00 (0.00%)
At close: Aug 13, 2025, 3:30 PM KST
Market Cap33.98B
Revenue (ttm)21.20B
Net Income (ttm)-1.43B
Shares Out8.59M
EPS (ttm)-196.56
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume38,906
Average Volume26,149
Open3,950.00
Previous Close3,955.00
Day's Range3,895.00 - 3,975.00
52-Week Range3,575.00 - 8,440.00
Betan/a
RSI47.32
Earnings Daten/a

About Avid Bioservices

MFC Co., Ltd. operates as a pharmaceutical company in South Korea. It specializes in research and development of pharmaceuticals; and provides APIs, pharmaceutical intermediates, Pd catalyst, and custom manufacturing services. The company was incorporated in 2008 and is based in Hwaseong-si, South Korea. [Read more]

Industry Non-operating Establishments
Founded 2008
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 432980
Full Company Profile

Financial Performance

In 2024, MFC Co., Ltd.'s revenue was 20.60 billion, an increase of 19.04% compared to the previous year's 17.31 billion. Losses were -1.18 billion, 63.9% more than in 2023.

Financial Statements

News

There is no news available yet.